Livanova Plc
A global medical technology company that builds devices for cardiac surgery and neuromodulation, including VNS Therapy — an implanted system that sends gentle electrical pulses to the vagus nerve to help people with drug-resistant epilepsy have fewer seizures. It was created in 2015 when Houston's Cyberonics, a nerve-stimulation pioneer, merged with Italy's Sorin, a longtime maker of cardiac surgery equipment. The name blends "life" with the Latin "nova" (new), chosen from thousands of employee suggestions.
Sold 885.0K
Granted 252.5K · Sold 30.1K
Granted 30.7K
Granted 73.9K
Granted 45.3K · Bought 2.0K
Granted 41.9K
Granted 52.3K · Sold 4.0K
Granted 31.6K
Granted 76.1K · Sold 116.1K
Granted 13.9K · Sold 16.5K
Granted 30.4K
Granted 11.0K
Granted 26.0K
Granted 5.8K
Granted 15.9K
Granted 1.5K
Granted 14.6K
Granted 2.1K
Granted 20.7K · Bought 1.0K
Granted 11.0K · Bought 1.0K · Sold 13.8K
Granted 9.2K
Sold 4.0K
Granted 12.7K
Granted 12.2K
Granted 11.9K · Sold 250
Granted 23.2K · Sold 9.1K
Granted 9.2K
Granted 14.9K
Granted 11.2K
Granted 29.6K · Sold 8.3K
Granted 6.4K
Granted 9.3K
Granted 9.6K · Sold 10.6K
Granted 5.2K
Granted 6.4K
Granted 6.7K
Granted 9.4K · Sold 2.1K
Granted 2.6K
Granted 2.9K · Sold 450
Granted 869
Granted 5.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Equinox Two S.C.A. +1 co-filer10% owner · 18 transactions | — | 26.70Mas of Sep 2016 | — | — | 885.0K |
| McDonald DamienCEO, Director · 77 transactions | — | 116.2Kas of Mar 2023 | 252.5K | — | 30.1K |
| Ballester Andre MichelCEO · 8 transactions | — | 93.8Kas of Dec 2016 | 30.7K | — | — |
| Shvartsburg AlexChief Financial Officer · 48 transactions | — | 44.6K | 73.9K | — | — |
| Kozy William ADirector · 20 transactions | — | 38.2K | 45.3K | 2.0K | — |
| Andrle EdwardGeneral Manager, NM · 15 transactions | — | 36.1Kas of Oct 2019 | 41.9K | — | — |
| Huston Thad AllenChief Financial Officer · 26 transactions | — | 31.7Kas of May 2020 | 52.3K | — | 4.0K |
| Bolton StephaniePresident, Global Epilepsy · 6 transactions | — | 30.6K | 31.6K | — | — |
| Moore Daniel JeffreyDirector · 64 transactions | — | 29.6Kas of Jun 2024 | 76.1K | — | 116.1K |
| Darnaud MichelPresident Cardiac Surgery · 1 transaction | — | 28.3Kas of Feb 2016 | — | — | — |
| Wise David SChief Administrative Officer · 19 transactions | — | 27.9Kas of Jan 2019 | 13.9K | — | 16.5K |
| Makatsaria VladimirChief Executive Officer, Director · 4 transactions | — | 25.3K | 30.4K | — | — |
| Rosenthal Arthur LDirector · 12 transactions | — | 23.6Kas of Jun 2022 | 11.0K | — | — |
| Hebbelinck TruiChief Human Resources Officer · 36 transactions | — | 19.3Kas of Mar 2024 | 26.0K | — | — |
| Mauro DemetrioChief Integration Officer · 2 transactions | — | 18.8Kas of Dec 2015 | 5.8K | — | — |
| Enxing Seng StacyDirector · 12 transactions | — | 15.8K | 15.9K | — | — |
| Shinmar PritpalSR VP Global Market Access · 2 transactions | — | 15.7Kas of Feb 2016 | 1.5K | — | — |
| Di Lullo StefanoPres Cardiac Rhythm Mgmt · 1 transaction | — | 14.4Kas of Feb 2016 | — | — | — |
| Schermerhorn Todd CDirector · 11 transactions | — | 13.1K | 14.6K | — | — |
| Sheridan BrianSR VP Genl Counsel & Secretary · 2 transactions | — | 13.1Kas of Feb 2016 | 2.1K | — | — |
| O'Kane SharonDirector · 21 transactions | — | 12.9Kas of Jun 2025 | 20.7K | 1.0K | — |
| Novak Alfred JDirector · 22 transactions | — | 12.6Kas of Jun 2022 | 11.0K | 1.0K | 13.8K |
| Poletti FrancoPresident, Cardiopulmonary · 13 transactions | — | 12.3K | 9.2K | — | — |
| Gutedel JacquesPresident Intercontinental · 2 transactions | — | 10.9Kas of Aug 2016 | — | — | 4.0K |
| Saia Andrea LynnDirector · 14 transactions | — | 10.8Kas of Dec 2023 | 12.7K | — | — |
| Wilver Peter MDirector · 8 transactions | — | 10.8K | 12.2K | — | — |
| Story BrookeDirector · 9 transactions | — | 10.3K | 11.9K | — | 250 |
| Bianchi FrancescoDirector · 26 transactions | — | 9.6K | 23.2K | — | 9.1K |
| Barry James ChristopherDirector · 6 transactions | — | 8.4K | 9.2K | — | — |
| Skeffington Keyna PidcockGeneral Counsel · 54 transactions | — | 8.1Kas of Sep 2022 | 14.9K | — | — |
| Hutchinson Michael DamonSVP, CLO and Company Secretary · 10 transactions | — | 7.9K | 11.2K | — | — |
| Dolci MarcoPresident CP · 48 transactions | — | 6.8Kas of Mar 2023 | 29.6K | — | 8.3K |
| Podlogar Susan MDirector · 4 transactions | — | 6.1K | 6.4K | — | — |
| Tezel AhmetChief Innovation Officer · 6 transactions | — | 6.1K | 9.3K | — | — |
| Morrison Hugh MDirector · 15 transactions | — | 5.3Kas of Jun 2021 | 9.6K | — | 10.6K |
| Sehgal VividCFO · 2 transactions | — | 5.2Kas of Mar 2017 | 5.2K | — | — |
| Kozmina NataliaChief Human Resources Officer · 2 transactions | — | 5.0K | 6.4K | — | — |
| Khoury RoyPresident, International · 16 transactions | — | 4.0Kas of Mar 2021 | 6.7K | — | — |
| Manko Douglas JohnChief Accounting Officer · 23 transactions | — | 3.3Kas of Mar 2020 | 9.4K | — | 2.1K |
| Zurbay DonaldDirector · 2 transactions | — | 2.6K | 2.6K | — | — |
| Simpson AlistairGeneral Manager, CS · 7 transactions | — | 1.9Kas of May 2019 | 2.9K | — | 450 |
| Vecchi PieroVP & Controller · 2 transactions | — | 1.9Kas of Feb 2016 | 869 | — | — |
| Gianotti StefanoDirector · 6 transactions | — | 1.8Kas of Mar 2018 | 5.9K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -1.10M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.